Novo Nordisk A/S has issued its 2025 annual report, available in iXBRL format. The leading global healthcare company, founded in 1923 and headquartered in Denmark, aims to defeat chronic diseases, particularly diabetes. With about 68,800 employees in 80 countries, Novo Nordisk markets its products in around 170 countries. The company’s B shares are listed on Nasdaq Copenhagen (Novo-B) and ADRs on the New York Stock Exchange (NVO). For more information, visit their website or social media channels. Contact the company for further details on their recent announcement.

Read more at GlobeNewswire: Novo Nordisk has published its annual report for 2025